and for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis. [5] Doripenem is currently under review for the treatment of hospital-acquired pneumonia (HAP ...

Spero Therapeutics ( (SPRO) ) has released its Q3 earnings. Here is a breakdown of the information Spero Therapeutics presented to its ...

Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025 Reiterate cash runway into ...

Most UTI will be treated by oral antibiotics and supportive measures after your pediatrician tests the baby’s urine. Complicated UTI where infection reaches the kidney will need Injectable antibiotics ...

The Miller sisters get up close and personal in an episode that shows just how much they’ve come to rely on each other.

On track to file New Drug Applications (NDAs) for NRX-100 (IV Ketamine) in treating suicidal ideation in depression, including bipolar depression and NRX-101 (Oral D-Cycloserine/Lurasidone) for ...

The diagnosis of symptomatic UTI among older adults is complicated by the high prevalence of asymptomatic bacteriuria, which does not require any treatment, and the difficulty in interpreting the ...

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...

Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025 Reiterate cash runway into mid-2026; Q3 2024 ending cash balance of $76.3M CAMBRIDGE, Mass., Nov. 14 ...

Medicare Advantage patients in the last year of life were far more likely to switch to traditional Medicare, shifting costs ...

Never miss Somerset's latest and breaking news again by signing up to our Daily Newsletter ...